295
Views
10
CrossRef citations to date
0
Altmetric
Research Article

β-Cyclodextrin-based ternary complexes of haloperidol and organic acids: the effect of organic acids on the drug solubility enhancement

, &
Pages 715-722 | Received 08 Dec 2016, Accepted 17 Jun 2017, Published online: 11 Jul 2017
 

Abstract

Haloperidol (HALO) is a weak base with very low aqueous solubility that is used as an antipsychotic drug. This study aimed to improve its solubility by forming HALO/β-cyclodextrin (β-CD)-based ternary complexes with organic acids. The solubility of HALO/β-CD binary and HALO/β-CD/organic acid ternary complexes in different media (i.e. citrate buffer pH 3 and 6) was explored. The stoichiometric ratio between the drug and β-CD was 1:1 in all complexes formed. The solubility of HALO/β-CD binary complexes significantly increased in citrate buffer pH 3 compared with citrate buffer pH 6. For the ternary complexes, HALO/β-CD/tartaric acid and HALO/β-CD/lactic acid in citrate buffer pH 3 increased HALO solubility compared with HALO/β-CD/succinic acid due to their higher unionized species. The highest stability constant and complexation efficiency values in citrate buffer pH 3 were shown by the ternary complexes with lactic acid followed by tartaric acid and succinic acid, respectively. Results indicated that lactic acid provided the greatest binding strength and solubilization efficiency for the complex.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This research is financially supported by the Thailand Research Fund and Mahidol University (RSA5780045 to D. Chantasart). This research is also supported in part by the Graduate Studies of Mahidol University Alumni Association (to P. Rakkaew) and the Thailand Research Fund and Faculty of Pharmacy, Mahidol University (IRG5780007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.